First, I need to recall the guidelines for dual antiplatelet therapy (DAPT) after stent placement. Bare metal stents (BMS) require DAPT for a certain period to prevent stent thrombosis. I remember that drug-eluting stents (DES) require longer DAPT, maybe a year or more, but BMS is shorter. Wait, is it 1 month? Or maybe 4-6 weeks? Let me think. The core concept here is the standard duration for BMS.
So, the core concept would be the recommended duration of DAPT after BMS placement. The correct answer is likely 1 month. The options probably include 1 month, 3 months, 6 months, etc. The other options would be incorrect because DES requires longer, and some options might be too short or too long.
For the explanation, I need to mention that BMS requires DAPT for 1 month to prevent in-stent thrombosis. The mechanism is that the stent causes endothelial injury, leading to platelet activation. Aspirin is always used, plus a P2Y12 inhibitor like clopidogrel. The duration is shorter than DES because BMS doesn't have a polymer coating that delays healing.
Wrong options: If an option says 12 months, that's for DES. 6 weeks might be a distractor. Also, some might confuse the duration with ACS management, which is 12 months regardless of stent type.
Clinical pearl: Remember BMS is 1 month, DES is 6-12 months. Mnemonic: B for Bare, 1 month; D for Drug-eluting, longer duration.
Need to check if the correct answer is A, B, etc. The user hasn't provided the options, but the correct answer is the one that says 1 month. So the final answer would be the option corresponding to one month.
**Core Concept**
The question tests knowledge of dual antiplatelet therapy (DAPT) duration following bare metal stent (BMS) placement. BMS requires a minimum 1-month DAPT to prevent early stent thrombosis, while drug-eluting stents (DES) necessitate longer therapy (6β12 months).
**Why the Correct Answer is Right**
Bare metal stents cause endothelial injury, triggering platelet aggregation. DAPT (aspirin + P2Y12 inhibitor, e.g., clopidogrel) is recommended for **at least 1 month** post-BMS to prevent in-stent thrombosis. This duration allows endothelial healing without excessive bleeding risk. Clinical trials (e.g., BMS guidelines) confirm that shorter durations increase thrombosis risk, while longer durations offer no benefit and increase bleeding.
**Why Each Wrong Option is Incorrect**
**Option A:** 1 week β Insufficient to prevent acute stent thrombosis; BMS requires β₯1 month.
**Option B:** 3 months β Appropriate for DES, not BMS.
**Option D:** 12 months β Excessive for BMS; increases bleeding risk
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.